Curium Advances Second Cyclotron Investment Plan in Romania to Expand PET Imaging Access

31 July 2026 | Friday | News

The proposed facility in the Cluj-Napoca region will strengthen PET imaging supply, improve access to nuclear medicine services across Northern Romania, and support the country's long-term healthcare infrastructure.

Curium™ announced it is advancing plans for a second cyclotron investment in Romania, reaffirming the company’s long-term commitment to expanding access to advanced nuclear medicine in the region and strengthening the country’s healthcare infrastructure.

Following an extensive assessment of market opportunities, technical requirements and regional infrastructure, Curium has identified a preferred location in the Cluj-Napoca region and a preferred local partner. Preparatory activities are now underway to support the next phase of the project.

The additional production capacity is intended to further strengthen supply for PET imaging, improve patient access to advanced diagnostic procedures and support the continued development of nuclear medicine services across Northern Romania and neighboring markets.

The proposed investment builds upon Curium’s established presence in Romania and the company’s continued focus on innovation, operational excellence and sustainable healthcare infrastructure.

Ciril Faia, CEO Curium International said: “Advancing this project reflects Curium’s confidence in Romania’s potential and our long-term commitment to helping strengthen access to essential nuclear medicine services across the region. By investing in additional capacity and working closely with local partners and healthcare stakeholders, we aim to support more reliable access to PET imaging and help advance diagnostic care for patients.”

 

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close